Qi Z, Ha T, Feng W, Karnoub M, et al. Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies Arch Pathol Lab Med 2024 Sep 20. doi: 10.5858/arpa.2024-0014.
PMID: 39299708